9926:HKG
Akeso Inc
HK$ ९१.३०
arrow_upward
+०.९४%(+०.८५) 1D
अक्टोबर १६, १६:०८:१४ GMT+८ · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$ ९२.१५
High
HK$ ९५.३०
Low
HK$ ९०.१५
Mkt. cap
८४.१० अरब
Avg. vol.
१.०४ करोड
Volume
१.११ करोड
52-wk high
HK$ १५६.००
52-wk low
HK$ ८०.२०
EPS
-HK$ १.२४
No. of employees
४ हजार
Open
HK$ ९२.१५
High
HK$ ९५.३०
Low
HK$ ९०.१५
Mkt. cap
८४.१० अरब
Avg. vol.
१.०४ करोड
Volume
१.११ करोड
52-wk high
HK$ १५६.००
52-wk low
HK$ ८०.२०
EPS
-HK$ १.२४
No. of employees
४ हजार
News stories
From web sources and news partners
Yahoo Finance
·
४७ मिनेट पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
Kalkine Media
·
१ घण्टा पहिले
Why Is Aurora Cannabis (NASDAQ:ACB) Climbing as Reform Hopes Resurface Today?
AOL.com
·
३७ मिनेट पहिले
Dow Futures Rise Despite 'Black Monday' Calls: Market Commentator Says Selloff Worries Are 'Overdone'
Bloomberg.com
·
९ घण्टा पहिले
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees४.०८ हजार
Founded२०१२ मार्च १९
Headquarters-
Sector-
Websiteakesobio.com